Drugs / OCPM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00437502 | Mar 2007 → Jan 2010 | female reproductive organ cancer | Michael Morse, MD | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OCPM | “Two cohorts of 9 patients each will be treated with different doses of the OCPM vaccine.” NCT00437502 ↗ |
| Route | Subcutaneous | “administered as x1 weekly injection given intradermally/subcutaneously” NCT00437502 ↗ |